Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chandrav De

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Nature Biotechnology|September 16, 2022
Author Correction: Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipientsTobias Deuse, Xiaomeng Hu, Alessia Gravina, et al.
JCI Insight|May 9, 2023
Human T cells efficiently control RSV infectionChandrav De, Raymond J Pickles, Wenbo Yao, et al.
The Journal of Clinical Investigation|June 15, 2023
An allosteric inhibitor of sirtuin 2 deacetylase activity exhibits broad-spectrum antiviral activityKathryn L Roche, Stacy Remiszewski, Matthew J Todd, et al.
Research Square|September 30, 2020
Acute SARS-CoV-2 Infection is Highly Cytopathic, Elicits a Robust Innate Immune Response and is Efficiently Prevented by EIDD-2801Angela Wahl, Lisa Gralinski, Claire Johnson, et al.
Nature Biotechnology|August 28, 2019
Precision mouse models with expanded tropism for human pathogensAngela Wahl, Chandrav De, Maria Abad Fernandez, et al.
Nature|February 9, 2021
SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801Angela Wahl, Lisa E Gralinski, Claire E Johnson, et al.
Nature|January 24, 2020
Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivoChristopher C Nixon, Maud Mavigner, Gavin C Sampey, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Nature Biotechnology|September 16, 2022
Author Correction: Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipientsTobias Deuse, Xiaomeng Hu, Alessia Gravina, et al.
JCI Insight|May 9, 2023
Human T cells efficiently control RSV infectionChandrav De, Raymond J Pickles, Wenbo Yao, et al.
The Journal of Clinical Investigation|June 15, 2023
An allosteric inhibitor of sirtuin 2 deacetylase activity exhibits broad-spectrum antiviral activityKathryn L Roche, Stacy Remiszewski, Matthew J Todd, et al.
Research Square|September 30, 2020
Acute SARS-CoV-2 Infection is Highly Cytopathic, Elicits a Robust Innate Immune Response and is Efficiently Prevented by EIDD-2801Angela Wahl, Lisa Gralinski, Claire Johnson, et al.
Nature Biotechnology|August 28, 2019
Precision mouse models with expanded tropism for human pathogensAngela Wahl, Chandrav De, Maria Abad Fernandez, et al.
Nature|February 9, 2021
SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801Angela Wahl, Lisa E Gralinski, Claire E Johnson, et al.
Nature|January 24, 2020
Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivoChristopher C Nixon, Maud Mavigner, Gavin C Sampey, et al.
Pageof 2